Clinical Trials Directory

Trials / Unknown

UnknownNCT05514652

Anesthesia Standard Operating Procedure During On-pump Coronary Artery Bypass Grafting

Development of Anesthesia Standard Operating Procedure During On-pump Coronary Artery Bypass Grafting Due to Coronary Heart Disease

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Heart Institute, Ministry of Health of Ukraine · Academic / Other
Sex
All
Age
44 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Background: Despite improvements in surgical and anesthesia procedures over the past 15 years complications during cardiac surgery still remain high. Bridgewater B et al. describes mortality during on-pump coronary artery bypass grafting (CABG) at 2%-3%, and the rate postoperative complications about 20%-30%. At the same time, the standard of care in patients undergoingon-pump CABG is not fully established. Hypothesis, Research Need: Use of multimodal low-dose opioid anesthesia during CABG decreases inflammatory response and the incidence of early postoperative cardiac complications due to a reduction in interleukin-6. Methodology: According to anesthesia standard protocol, all patients were divided into two groups - study group with multimodal low-dose opioid anesthesia (60 patients) and control group with a high-dose opioid anesthesia (60 patients). Primary (IL-6 at the end of the operation) and secondary clinical outcomes (postoperative atrial fibrillation (POAF), low cardiac output syndrome (LCOS), duration of mechanical ventilation (MV), length of intensive care unit (ICU) stay, length of hospital stay) were compared between the groups. Analysis Tools: Clinical observations; instrumental research methods (electrocapdiography, echocardiography); labs (blood gases, hemoglobin, electrolytes); enzyme-linked immunosorbent assay (IL-6); statistical (Student's t-test, Mann-Whitney U test, χ2-test, correlation analysis). Expected Outcomes: Use of multimodal low-dose opioid anesthesia during CABG will decrease inflammatory response (lower levels of IL-6 at the end of the surgery) and the incidence of early postoperative cardiac complications, expressed as lower incidence of LCOS and POAF, lower duration of MV and lower length of ICU stay.

Conditions

Interventions

TypeNameDescription
DRUGLow opioid anesthesiaMultimodal low-dose opioid protocol for anesthesia based on ketamine, lidocaine and dexmedetomidine

Timeline

Start date
2018-12-01
Primary completion
2021-10-01
Completion
2022-12-01
First posted
2022-08-24
Last updated
2022-08-24

Locations

1 site across 1 country: Ukraine

Source: ClinicalTrials.gov record NCT05514652. Inclusion in this directory is not an endorsement.